Please enter the email address you used to register, then we will send you a link to choose a new password
VRCA: 52% | Verrica Pharmaceuticals' Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
FSR: 11% | Fisker Says It Rolled Out Final Fisker Ocean Over-the-Air Software Update Of 2023, Company Prepares For Regular Updates In 2024
SGRY: -6% | Surgery Partners shares are trading lower after the company announced a proposed secondary offering of common stock.
Posted In: FSR SGRY VRCA